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A lot of molecules play fundamental roles in neoplasic processes and cancer. 
Heat shock proteins may enhance these pathologies and favor the protumoral 
milieu. However, a look at the literature tells us that these molecules intervene 
in both to promote or attack cancer cells. In the case of breast cancer is known 
that Hsp70 (isoform 2) improve its establishment and progression in the patient, 
and is possible that the ATPase domain of Hsp70-2 favors this disease. Thus, is 
relevant to know if this molecular region has immunogenic activity as well as 
which epitopes are essential to stimulate immune cells, and whether could 
induce the attack of the tumor mass. In this aim, the immunogenicity of 
ATPase domain of Hsp70-2 was studied in silico. The results suggest that the 
majority of the molecule had immunogenic epitopes that boosts the immune 
response through activation of B cells and T cells. However, in vitro synthesis 
and in vivo experimental studies to evaluate the efficacy of this therapeutic 
candidate are required to ensure safety in people.  
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1. INTRODUCTION  
Breast cancer (BC) is one of the leading causes of death of women worldwide and is listed as a serious 
problem in public health [1-2]. Breast cancers mostly may include two hystotypes: invasive type such as 
infiltrating ductal carcinoma (IDC) and non-invasive type, as Ductal Carcinoma in-situ (DCIS) [3]. The first one 
cause inflammatory breast cancer that is characterized by its fast and aggressive behavior and the patients have a 
43% increased of risk of death. However, despite clinical differences, these cancers shared certain similarities 
and plasma membrane proteins are one them [4]. Therefore, these molecules serve as targets in 70% of cancer 
therapies at clinical and experimental level [5]. Thus, identification and study of new molecules associated to 
BC can aid to early diagnosis and enhance new therapeutics.  
Heat shock proteins (Hsps) are molecular chaperones that may modifying the structures and 
interactions of other proteins [6]. They shift the balance from denatured, aggregated protein conformation 
toward ordered, functional conformation, and are particularly in demand when proteins are disordered by heat 
shock, oxidative stress, or other protein-damaging events [7-9], intervening both co-translationally and post-
translationally, at the same time as improve cell life to such stress factors [10].  
Few works focus in the association between Hsps and BC. But recently studies show that HSP27, 
HSP90 Y HSP70 can contribute in the establishing and progression of this pathology [11-15]. Regarding the 
HSP70 family, eight members have been identified with a high structural and functional homology but with 
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different intracellular localizations [16]. Nevertheless, during cell stress Hsps go to extracellular milieu, existing 
as free proteins or anchor in the plasma membrane in the context of cholesterol-rich microdomains (lipid rafts) 
[17-18].  
Gabriele Multhoff et al. in 1995 made the first report of the selective expression of a form of Hsp70 on 
the plasma membrane of solid tumor cells—but not normal tissue—since then, we know that Hsp70 family is 
highly expressed on metastatic disease and is associated with both poor prognosis and low survival [19-21]. This 
is an important reason why membrane Hsp70 expression is consider as a universal, selective tumor-specific 
marker of aggressive disease [7]. In cancer the ATPase domain of Hsp70 is localized outside the plasma 
membrane [22] but until now how does it works at molecular level during disease is not well understood.  A 
most recent research found that Hsp70 isoform 2 is over expressed in BC patients and involved in malignant 
properties, by which it may be potential candidate molecule for development of better BC treatment [23].  
Due to the above, this paper evaluates the immunogenic capacity of the ATPase domain of Hsp70-2 as 
a possible inductor of the immune response promoted by B lymphocytes and T lymphocytes, using for this the 
in silico analysis given that have been demonstrated that this approach is one of the best tools for the design and 
evaluation of vaccines before starting the experimental study.  
 
 
2. RESEARCH METHOD  
2.1. Protein sequence retrevial 
The protein sequence of Hsp70-2 was retrieved in FASTA format from Uniprot Knowledgebase data, 
have also used accession Nos. P54652. The ATPase domain (also known as the nucleotide binding domain 
(NBD) was identified in the same database (http://www.uniprot.org/blast/?about=P54652[2-389]&key=Region).  
 
2.2. Optimization of the ATPase domain  
Through Jcat server the NBD was optimized (http://www.jcat.de/Start.jsp), this software allows the 
generation of a codon adaptation by avoiding cloning sites for restriction enzymes and Rho-dependent 
transcription terminators [24]. Through the Vaxijen server (http://www.ddg-
pharmfac.net/vaxijen/VaxiJen/VaxiJen.html) I predict the immunogenicity. This is the first server for the 
independent prediction of antigen alignment, that is, it allows classifying the antigen essentially based on the 
physicochemical properties of the protein without resorting to the sequence of alignment [25]. 
 
2.3. mRNA improved 
The nucleotide sequence of the protein was obtained from the Jcat server, and then it was introduced in 
the webserver Secuence Massager (http://www.attotron.com/cybertory/analysis/seqMassager.htm) to get the 
RNA sequence and finally the structure. The gene was analyzed by the RNAfold program 
(http://rna.tbi.univie.ac.at//cgi-bin/RNAWebSuite/RNAfold.cgi).  
 
2.4. Secondary and tertiary structure prediction analysis 
These analyzes were carried out with the “The Predict Protein server” (https://www.predictprotein.org), 
which predicts secondary structure elements and solvent accessibility using evolutionary information from 
multiple sequence alignments and a multi-level system [26]. The 3D structure of the ATPase domain of HSPA2 
was executed on the I-TASSER online server (https://zhanglab.ccmb.med.umich.edu/I-TASSER/), this is a 
hierarchical approach to protein structure and function prediction. It first identifies structural templates from the 
PDB by multiple threading approach LOMETS, with full-length atomic models constructed by iterative 
template fragment assembly simulations [27]. 
 
2.5. The physico-chemical parameters evaluation 
The physico-chemical parameters such as theoretical isoelectric point (pI), molecular weight, total 
number of positive and negative residues, extinction coefficient, half-life, instability index, aliphatic index, and 
grand average hydropathy (GRAVY) were computed using the Expasy’s ProtParam 
(http://us.expasy.org/tools/protparam.html). 
 
2.6. Prediction of possible transmembrane sequences 
Due to the fact that during BC the Hsp70-2 is overexpressed in the plasma membrane, it was necessary 
to determine if this molecule possesses a specific sequence that facilitates its anchor in this cellular region, for 
which the complete aminoacidic sequence was upload in the Octopus online server 
(http://octopus.cbr.su.se/index.php), which uses a novel combination of hidden Markov models and artificial 
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neural networks, and predicts the correct topology for 94% of the a dataset of 124 sequences with known 
structures [28]. 
 
2.7. Prediction of epitopes for B lymphocytes and T lymphocytes. 
The amino acid sequence of interest was submitted to online servers to predict continuous and 
discontinuous epitopes for B lymphocytes, using BCPRED (http://ailab.ist.psu.edu/bcpred/) and Discotope 
(http://tools.iedb.org/discotope) respectively. The access code for Discotope was obtained through Protein Data 
Bank: 3i33 (HSP70-2: ATPase domain). 
The prediction of epitopes for T cells was performed through CTLpred 
(http://www.imtech.res.in/raghava/ctlpred/).  
 
2.8. Prediction of MHC binding peptides 
The prediction of binding peptides to MHC class-I was carried out by applying Propred-I 
(http://www.imtech.res.in/raghava/propred1/), while the prediction of MHC class-II binding peptides was 
performed through the online server RANKEP (http://imed.med.ucm.es/Tools/rankpep.html).  
 
2.9. Prediction of IgE epitopes and allergic sites 
Additionally, using Algpred (www.imtech.res.in/raghava/algpred/) the sites with allergenic potential 
were predicted.  
 
 
3. RESULTS AND ANALYSIS  
3.1. Optimization of the ATPase domain 
To date there have been no studies that indicate that the NBD to be effective in immunization 
processes. But its over-expression in several BC hystotypes becomes it in an ideal target for the development of 
immunotherapy. One of the most important steps in designing synthetic genes is codon optimization. Codon bias 
and CG content was calculated. The codon adaptation index (CAI) was 0.96 and the CG content was reduced 
from 66.40% to 40.89%, favoring in this way the increase of the mRNA stability of the molecule (Figure 1). The 
antigenic index was 5.2 that allow classifying this molecule as a possible tumor antigen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Graphical view of codon usage in optimized ATPase domain of Hsp70-2. 
 
3.2. mRNA improved 
Expression of proteins is significantly dependent on mRNA secondary structure, which confers 
beneficial roles such as regulation of gene expression. To perform this analysis, it was essential to use the 
minimum free energy for secondary structures formed by DNA molecules. The best structure released by 
RNAfold had a ΔG = -481.32 kcal/mol without formation of loops at the 5'-end.  
In addition, this bioinformatics tool allowed visualizing the differences between the crude secondary 
structure of the RNA of the ATPase domain with respect to the secondary structure improved and thrown by the 
server using the minimum of free energy (MFE) necessary to reach an adequate folding (Figure 2).  This Free 
energy minimizations can elucidates RNA secondary structure because it may aid in the determination of a 
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comparative sequence analysis model or suggest possible structures to test by site-directed mutagenesis or other 
methods [29]. 
The results from mRNA prediction indicated that the mRNA had enough stability for effective 
translation in the host. Therefore, based on this I can expect to increase the translation rates, half-lives, and 
transcript number of this molecule in the host. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Prediction of ATPase domain RNA secondary structure by RNAfold, the color scale indicates 
the probability of base pairing formation (A). Representation of the MFE structure, the thermodynamic 
ensemble of RNA structures, and the centroid structure. Additionally is present the positional entropy for each 
position (B).  
 
3.3. Secondary and tertiary structure prediction analysis 
Three states of secondary structure were predicted: helix (H; includes alpha-, pi- and 3_10-helix), 
(beta-)strand (E = extended strand in beta-sheet conformation of at least two residues length) and loop (L) 
(Figure 3). Secondary structure is predicted by a system of neural networks with an expected average accuracy 
of more than 72% [26]. On the other hand, for each target, I-TASSER simulations generate a large ensemble of 
structural conformations, called decoys. To select the final models, I-TASSER uses the SPICKER program to 
cluster all the decoys based on the pair-wise structure similarity, and reports up to five models which 
corresponds to the five largest structure clusters. The confidence of each model is quantitatively measured by C-
score that is calculated based on the significance of threading template alignments and the convergence 
parameters of the structure assembly simulations. C-score is typically in the range of (-5, 2), where a C-score of 
a higher value signifies a model with a higher confidence and vice-versa [27], this was the case of the ATPase 
domain evaluated with a C-score of 1.50. Also, in these results I-TASSER simulations converge had less than 5 
clusters generated indicating that the model has a good quality because of the converged simulations.  
 
3.4. The physico-chemical parameters evaluation 
The calculated molecular weight and the theoretical pI of the ATPase domain of HSPA2 was 42.4 KD 
and 6.63 respectively. The extinction coefficient of the molecule at 280 nm measured in water was 19. 035 
M/cm. Half-life was estimated to be 1.9 h in mammalian reticulocytes (in vitro), >20 h in yeast (in vivo) and 
>10 h in Escherichia coli (in vivo). Similarly, the aliphatic index and Grand average of hydropathicity 
(GRAVY) were obtained: 83.99% and -0.334 respectively. The instability index classified the molecule as 
stable (instability index: 35.17). 
 
3.5. Prediction of possible transmembrane sequences 
The evaluation of this parameter did not yield results that indicate the presence of a transmembrane 
region in the natural conformation, that is, under normal physiological conditions (Figure 5). However, it is 
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presumed that during the beginning and evolution of BC could be induced post-translational modifications, and 
thus alter the protein conformation by incorporating new elements in their structure enhancing their anchoring to 
the plasma membrane [10, 22]. Besides, vesicular transport and ubiquitination-transport have been proposed as 
mechanisms [30-31], and they also serve for releasing of exosomes into the extracellular space.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. ATPase domain of Hsp70-2: Secondary structure composition an solvent accessibility. 
 
 
 Table 1. States of secondary structure predicted for ATPase domain of Hsp70-2: helix (H; includes 
alpha-, pi- and 3_10-helix) and (beta-)strand (E = extended strand in beta-sheet conformation of at least two 
residues length) 
. 
State % H %E 
All-alpha >45 <5 
All-beta <5 >45 
Alpha-beta >30 >20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Predicted 3D structure of ATPase domain of Hsp70-2 using I-TASSER software. 
 
 
Various hematopoietic and non-hematopoietic cells secretes exosomes, including mostly 
macrophages, B and T lymphocytes, mast cells, platelets, alveolar lung cells, tumor cells and intestinal epithelial 
cells respectively. The  tumor cells secreted exosomes rich in Hsp70, but the role of exosomal-associated Hsps 
Secondary structure composition Solvent accessibility 
I 
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in cancer remain controversial because they can promote pro-inflamatory and anti-inflamatory effects depending 
on cellular origin and type of cancer [31-35], for example in BC the Hsp70-2 may aid progress the disease [23]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. ATPasa domain of Hsp70-2: improving topology prediction by two-track ANN-based preference 
scores and an extended topological grammar using Octopus server. 
 
 
3.6. Prediction of epitopes for T lymphocytes and B lymphocytes. 
The prediction of CTL epitopes is represented in Table 2. The sequential epitopes were analyzed 
through the online Bcpred server. All 16-mers with Bcepred cutoff score >0.9 in B-cell epitopes were selected 
(Table 3). In addition, the conformational epitopes were chosen based on the following criteria: hydrophilicity, 
antigenicity, flexibility, accessibility, polarity, and exposed Surface (Table 4). The prediction of conformational 
epitopes (68), performed with Discotope is shown in Table 5. The identified epitopes on protein surface could 
interact easily with antibodies, and they were generally flexible.  
 
Table 2. Prediction of T-cell epitope by CTLPred for ATPase domain of Hsp70-2. 
Peptide rank Start position sequence Score 
1 25 KVEIIANDQ 1.000 
2 108 KGETKTFFP 1.000 
3 160 DAGTITGLN 1.000 
 
 
Table 3. B-Cell epitopes from full length proteins using Bcepred for ATPase domain of Hsp70-2. 
Position Epitope Score Rank 
245 EEFKRKHKKDIGPNKRAVRR 1 1 
2 ARGPAIGIDLGTTYSCVGVF 0.998 2 
98 GGKPKVQVEYKGETKTFFPE 0.994 3 
357 NGKELNKSINPDEAVAYGAA 0.994 4 
149 YFNDSQRQATKDAGTITGLN 0.932 5 
28 IIANDQGNRTTPSYVAFTDT 0.862 6 
74 IGRKFEDATVQSDMKHWPFR 0.832 7 
222 KSTAGDTHLGGEDFDNRMVS 0.810 8 
325 DAKLDKGQIQEIVLVGGSTR 0.744 9 
Table 4. Epitopes predicted in HSPA2-ATPasa domain by different parameters. 
Prediction Sequence 
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Parametre 
Flexibility IIANDQGNRTT, FRVVSEGGK, VEYKGET,  AYFNDSQ, FEVKSTA,  
HLAEEFKRKHK, TACERAKRTLSSSTQ, IVLVGGS, FNGKELN, ILIGDKSE 
Accessibility  ANDQGNRTTPSYVAFTDTERL, GDAAKNQ, KRLIGRKFEDATVQSDMKHWP,  
SEGGKPKVQVEYKGETKTFFPEE, TKMKEIAE, YFNDSQRQATKDA, AYGLDKKG,  
GEDFDNRM, LAEEFKRKHKKDIGPNKRAVRRLRTACERAKRTLSSS, 
TSITRARFEEL, TLEPVEKALRDAKLDKGQIQE, GSTRIPKIQK, NGKELNKSINPDE 
Exposed Surface KRLIGRK, KPKVQVEYKGETKT, SQRQATKD, AEEFKRKHKKDIGPNKRAVRR, 
ERAKRTL, RDAKLDK, RIPKIQK, NGKELNK, DKSE 
Antigenic 
Propensity 
GTTYSCVGVFQHGKV, HWPFRVVSE, PKVQVEYK, LNVLRII, NVLIFDLG, 
TFDVSILTIE,QIQEIVLVGGST 
Hydrophilicity ANDQGNRTTPS, GDAAKNQ, EDATVQSD, SEGGKPK, EYKGETKT, 
NDSQRQATKDAGT, DKKGCAGGEKN, VKSTAGDTH, GGEDFDNR, KRKHKKD, 
SSSTQAS, DKGQIQE, GDKSE 
Polarity FQHGKVEI, AKRLIGRKFEDAT, MKHWPFRV, KPKVQVEYKGETKTFFPEE, 
VLTKMKEIAE, 
GEDFDNRMVSHLAEEFKRKHKKDIGPNKRAVRRLRTACERAKRTLS, 
ITRARFEELNA,  TLEPVEKALRDAKLDKG, RIPKIQK, NGKELNKSI, DKSE 
Turns YFNDSQR 
 
3.7. Prediction of MHC binding peptides 
Predicted peptides for binding to MHC-I over multiple alleles including MHC-2Kb, MHC-Db, MHC-
2Dd, MHC-2Kd, MHC-2Kk, and MHC-2Ld were selected and showed in Table 6. RANKPEP online server was 
applied to predict binding peptides to class II MHC molecules as shown in Table 7. 
 
3.8. Prediction of IgE epitopes and allergic sites 
 The protein sequence did not contain experimentally proven IgE epitope. 
 
Table 5. Conformational B-cell epitopes from full length protein using Discotope server for ATPase domain of 
Hsp70-2. 
Epitope Position  
HYS, GLY, THR, HIS, GLY, PRO, GLY, 
GLY, GLY, THR 
24, 25, 48, 90, 99, 258, 293, 35, 110, 
112 
GLU, GLY, ASP 292, 332, 47 
ALA, GLU, ASP 82, 111, 153 
LYS, LYS, ASN 251, 253, 259 
SER 365 
GLN, SER, LYS 34, 86, 89 
ARG 250 
ASP, ASN, GLY 330, 358, 359 
GLY, ASN 100, 152 
LYS, ASP, ASP, ASN, GLN, MET, GLU, 
ASP, THR, GLU, LYS, LYS, LYS, PHE, 
SER 
328, 355, 33, 36, 59, 62, 80, 81, 83, 
98, 109, 113, 139, 151, 154 
LYS, HIS, GLY, LYS 249, 252, 257, 260,  
LYS 351 
GLN, ASP, TRP, PRO 85, 87, 9, 92 
ARG, VAL, SER 94, 96, 97 
LYS 254 
PRO 357 
MET, PHE 88, 93 
 Table 5 continuation 
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GLN 157 
GLU, ASP 247, 255 
THR 65 
GLU 246 
ILE, ARG 256, 261 
ALA  245 
 
 
Table 6. The result of prediction for MHC-I epitopes. 
MHC type Start and End 
MHC-Db 21-29, 71-74, 76-77, 80-83, 85-91, 133-140, 184-187, 189-197, 229-237, 273-280, 30-307, 357-
361, 363-370, 372-379, 38-388, 395-401 
MHC-Dd 2-8, 10-16, 18- 20, 22-24, 26-33, 37-38, 40-47, 133-139, 141-148, 156-162,  180-183, 185-191, 
202-205, 207-208, 211-218, 224-230, 235-242,  250-257, 274-281, 310-316, 318-325, 339-346, 
349-357, 359-360, 363-370, 376-382, 384-390, 392-399    
MHC-Kb 22-27, 29-33, 37-38, 61-68, 92-99, 134-40, 164-171, 310-316, 318-324, 326-333, 363-370, 372-
379, 387-394 
MHC-Kd 39-46,  63-70, 78-82,  84-91,134-139, 141-148, 152-159, 180-181, 182-191, 201-208, 225-227, 
229-236, 241-248, 310-317, 322-328,  330-337, 356-363, 391-392, 394-401 
MHC-Kk 10-16, 20-27, 40-47, 62-64, 66-73, 88-93, 99-106, 124-131,136-139, 141-148, 150-153, 155-
162, 175-181, 184-190, 193-200, 210-217, 222-223, 225-227, 228-232, 234-241, 251-252, 254-
261, 288-293, 297-304, 310-317, 323-330, 356-363, 391-392, 394-401 
MHC-Ld 2-4, 6-8, 10-17, 3-39, 55-62, 81-88, 102-110, 134-136, 138-145, 161-167, 194-201, 230-237, 
241-244, 246-253, 258-266, 301-304, 306-313, 315-322, 366-373, 38-389 
 
 
Table 7. The result of prediction for MHC-II epitopes. 
Rank Pos. N Sequence C Mw (Da) Score % Opt. 
1 339 IVL VGGSTRIPK IQK 896.05 20.086 34.76 % 
2 293 YEG VDFYTSITR ARF 1083.21 15.948 27.60 % 
3 255 KKD IGPNKRAVR RLR 992.19 13.34 23.08 % 
4 140 GKV HSAVITVPA YFN 876.02 12.798 22.14 % 
5 166 TIT GLNVLRIIN EPT 993.21 11.413 19.75 % 
6 333 KGQ IQEIVLVGG STR 909.09 10.523 18.21 % 
7 244 SHL AEEFKRKHK KDI 1154.34 9.906 17.14 % 
8 249 EFK RKHKKDIGP NKR 1060.26 9.556 16.53 % 
9 377 GAA VQAAILIGD KSE 881.04 9.13 15.80 % 
10 300 TSI TRARFEELN ADL 1117.24 8.92 15.43 % 
11 310 LNA DLFRGTLEP VEK 1029.17 7.704 13.33 % 
12 108 VEY KGETKTFFP EEI 1036.19 7.453 12.90 % 
13 258 IGP NKRAVRRLR TAC 1150.4 6.476 11.21 % 
14 68 NTI FDAKRLIGR KFE 1057.27 6.464 11.18 % 
15 266 RRL RTACERAKR TLS 1072.26 6.411 11.09 % 
16 169 GLN VLRIINEPT AAA 1036.24 6.298 10.90 % 
17 354 LLQ DFFNGKELN KSI 1065.15 5.394 9.33 % 
18 345 STR IPKIQKLLQ DFF 1062.36 4.788 8.28 % 
19 163 DAG TITGLNVLR IIN 968.15 4.651 8.05 % 
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According to the in silico analyses presented above, the physico-chemical parameters evaluation 
indicates that this region of the Hsp70-2 protein is able to remain for a long period of time in bacterial cells (>10 
h) which would be useful for its obtaining and purification in the laboratory. The presence of a high percentage 
of negatively charged amino acids (Glu and Asp) on the accessible surface and the high flexibility of the 
evaluated immunogenic epitopes suggests that these can interact with the basic pockets of the union groove of 
the major histocompatibility complex (MHC) molecules on leukocytes and thus activating immune cells, as B 
cells and T cells, against the ATPase domain of Hsp70-2. This could improve the attack to the tumor mass 
through antibodies production and activation of T helper and cytotoxic cells [36]. In this sense, antibodies can 
serve to promote antibody-dependent cytotoxicity (ADCC) and complement attack, while pro-inflammatory 
cytokines secretion of T helper cells may aid to establish an acute inflammatory state that favors the anti-
tumoral effects [37]. However, are need in vitro and in vivo studies to check the efficacy and safety of this 
approach because it is known that in clinical trials a lot of vaccines deviate the “good” immune response to 
another worse, which has the ability to induce an unresponsiveness state that is promoted by antigenic 
presentation of the antigen by dendritic cells to T regulatory cells leading to suppress the immune response 
against cancer [37]. Additionally, the amount of loops and helix in the structure of this protein (Figure 4 and 5) 
reflects that it can have a wide versatility and, therefore, also variable functions, which will improve the tumor 
environment favoring its establishment and progression in the patient. 
 
 
4. CONCLUSION  
The several bioinformatics methods for immunogenicity prediction of the ATPase domain of Hsp70-2 
protein demonstrated that epitopes of this region could induce B cell and T cell–mediated immune responses 
successfully. Therefore, is suggested as a potential candidate for modulation and reduction of tumor mass. As 
the next steps to complete this study on vaccine development, I recommend in vitro synthesis and in vivo 
experimental studies to evaluate the efficacy of this potential vaccine. 
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